NDC codes

FDA NDC Directory
Product NDC (as listed)0575-6200Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00575-6200Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0575-6200-30005756200301 BOTTLE, DROPPER in 1 BOX (0575-6200-30) / 30 mL in 1 BOTTLE, DROPPERMarketed from Sep 30, 1990

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Proglycem
Generic name (nonproprietary)
diazoxide
Active ingredients
Diazoxide — 50 mg/mL
Dosage form
Suspension
Route
Oral
Labeler
Teva Pharmaceuticals USA, Inc.NDC labeler code 0575
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 017453
Marketing start
Listing expires
Identifiers
Product ID 0575-6200_451aa56d-e2e5-402f-843a-cddb5b3d37ddSPL ID 451aa56d-e2e5-402f-843a-cddb5b3d37ddSPL set ID b16c7832-2fd9-49af-b923-1dc0d91fd6e2RxCUI 197593, 207634UNII O5CB12L4FN

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400575620030 followed by a unit qualifier and the quantity

Package 00575-6200-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE PROGLYCEM is indicated for the management of hypoglycemia due to hyperinsulinism associated with the following conditions: Adults: Inoperable islet cell adenoma or carcinoma, or extrapancreatic malignancy. Infants and children: Leucine sensitivity, islet cell hyperplasia, nesidioblastosis, extrapancreatic malignancy, islet cell adenoma, or adenomatosis. PROGLYCEM may be used preoperatively as a temporary measure, and postoperatively, if hypoglycemia persists. PROGLYCEM should be used only after a diagnosis of hypoglycemia due to one of the above conditions has been definitely established. When other specific medical therapy or surgical management either has been unsucce…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0575-6200

What is NDC 0575-6200?
0575-6200 is the product NDC for Proglycem (diazoxide), Diazoxide 50 mg/mL suspension, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Proglycem (Diazoxide).
What is the active ingredient?
Diazoxide.
Who is the labeler?
Teva Pharmaceuticals USA, Inc., NDC labeler code 0575. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Proglycem?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in